Go Deep
Zura Bio Limited
Zura Bio Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,882 | -3.8 | 2.06 | 0.00 | 402.84 |
| Oct 2026 | 20,717 | -3.9 | 2.14 | 0.00 | 418.72 |
| Oct 2026 | 20,836 | -3.7 | 2.08 | 0.00 | 406.43 |
| Oct 2026 | 21,203 | -3.5 | 1.89 | 0.00 | 367.49 |
| Oct 2026 | 21,267 | -3.4 | 1.85 | 0.00 | 361.25 |
| Oct 2026 | 21,093 | -3.6 | 1.95 | 0.00 | 379.27 |
| Oct 2026 | 20,974 | -3.7 | 2.01 | 0.00 | 390.62 |
| Oct 2026 | 21,523 | -3.2 | 1.72 | 0.00 | 333.20 |
Zura Bio Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -26,304,000.0 | -24,223,000.0 | -17,175,000.0 | -18,040,000.0 |
| EPS | -0.2 | -0.2 | — | -0.2 |
Zura Bio Limited Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -68,650,000.0 | -52,403,000.0 | -60,360,000.0 | -25,738,000.0 |
| EPS | -1.1 | -0.6 | -2.1 | -12.2 |
Zura Bio Limited Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 113,948,000.0 | 179,533,000.0 | 100,843,000.0 | 5,262,000.0 | — |
| Total Liabilities | 12,410,000.0 | 19,514,000.0 | 21,292,000.0 | 27,318,000.0 | — |
| Total Equity | 101,538,000.0 | 146,815,000.0 | 59,330,000.0 | -32,056,000.0 | — |
Owes vs Owns
Zura Bio Limited owed $0.08 for every $1 it owned in Jun 2026, down from $5.19 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.08× | 0.11× | 0.11× | 0.21× | 5.19× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Zura Bio Limited Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 96.0%Other assets 3.9%
How it's funded — Dec 2025
Payables 1.1%Other liabilities 9.8%Shareholders' equity 89.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 109.4 | 176.5 | 99.8 | 1.6 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.1 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 4.4 | 2.9 | 1.0 | 3.7 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 7.8 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 1.3 | 0.7 | 2.7 | 2.0 |
| Other liabilities | 11.1 | 18.8 | 18.5 | 17.6 |
| Shareholders' equity | 101.5 | 160.0 | 79.6 | -22.1 |
| Net tangible assets | 101.5 | 146.8 | 59.3 | -32.1 |
Zura Bio Limited Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Operating Activities | -64,815,000.0 | -28,076,000.0 | -15,054,000.0 | -1,202,000.0 |
| Investing Activities | -113,000.0 | -5,075,000.0 | -8,000,000.0 | -12,000,000.0 |
| Financing Activities | -2,163,000.0 | 109,843,000.0 | 121,293,000.0 | 14,769,000.0 |